Market News & Trends
CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network
MONTREAL, CANADA – CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a Strategic Partnership with Sonic Healthcare USA, Inc. to launch the…
Lonza Advances Integrated DNA to IND Programs Through Acceleration, De Risking, and Innovation
Basel, Switzerland, – Lonza, the world’s leading CDMO, announced today a strengthening of its biologics development services with an enhanced preclinical development offering designed to help…
Deep Science Ventures and Medicines Discovery Catapult Partner to Accelerate Next Generation Brain Treatments
LONDON – Deep Science Ventures , a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into…
Microbot Medical Secures the First Healthcare System in North Carolina to Adopt the LIBERTY Endovascular Robotic System
HINGHAM, Mass., -- Microbot Medical Inc., developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that it has secured its first North Carolina-based…
Spherix Data Reveals Explosive Demand for Wegovy Pill as $100B Weight Loss Race Intensifies
EXTON, PA, Spherix, the leading independent market intelligence and advisory firm for the global life sciences industry, announced new research highlighting how the race to…
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers
Houston, Texas and Tuebingen, Germany, Immatics”, the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced…
Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers
BASEL, Switzerland – Nouscom, a clinical-stage biotech company developing next-generation immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease,…
Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push
Eli Lilly said it will buy three vaccine developers in deals worth up to $3.8 billion in combined value, signaling its push into infectious disease…
MannKind Announces FDA Approval of Afrezza, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient centric solutions for cardiometabolic and orphan lung diseases, today…
Recipharm boosts BFS capacity with strategic manufacturing investment
Recipharm, a global contract development and manufacturing organization (CDMO), today announced a multi-million investment in a new Blow-Fill-Seal (BFS) manufacturing line, expanding capacity to support…
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute
TOKYO – Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technology from The Noguchi Institute. This modality enables…
Cereno Scientific Doses First Volunteer in CS014 PK-bridging Study
Cereno Scientific, an innovative biotech pioneering treatment to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the first…
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, noted today that…
Orexo announces positive outcome from an in-vivo study of OX390
Uppsala, Sweden – Orexo AB, today announces positive data from a pre-clinical in-vivo study on the nasal absorption of atipamezole when delivered with Orexo’s AmorphOX…
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for central nervous system (CNS) cancers, today announces that it has…
FUJIFILM Cellular Dynamics Launches New iPSC Manufacturing Facility in Madison
Fujifilm Cellular Dynamics, Inc., a pioneering global developer and manufacturer of human-induced pluripotent stem cells (iPSCs), today celebrated the opening of its new headquarters and…
VoxCell BioInnovation & adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform
VoxCell BioInnovation Inc. (“VoxCell”), a developer of bioprinted vascularized human tissue models for preclinical drug development, and adMare BioInnovations (“adMare”), Canada’s life sciences company creation…
Vetter Starts Construction of a New Production Site in Germany
Vetter, a leading Contract Development and Manufacturing Organization (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking…
OrganaBio Acquires Excellos Operating Assets, Establishing a Coast-to-Coast Cell Therapy Contract Testing, Development & Manufacturing Organization
OrganaBio, LLC has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract development and manufacturing…
Terumo Blood & Cell Technologies & Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions, and Steminent Biotherapeutics have entered into a strategic collaboration to accelerate late-stage…
